Investigate New Indications, Discover New Results, Explore New Approaches, and Create New Connections to Move Your Therapeutic Program From the Lab to the Market

JUNE 21-24, 2022 | BOSTON, MA

Welcome to the 7th Microbiome Movement - Drug Development Summit

The 7th Microbiome Movement - Drug Development Summit returns to Boston at a pivotal time. As the microbiome therapeutic space matures, with more indications being pursued and more companies conducting trials, the focus of this event - now in its 7th year - is evolving to showcase these new studies. With this progress however comes new challenges, and we’re excited to once again be uniting over 300 microbiome pioneers to work towards overcoming these challenges and moving the whole industry closer to commercial approval. 

Continuing to unite the most forward-thinking researchers from the biopharmaceutical industry, our unrivaled program will uncover microbiome functionality and mechanisms, decipher translation issues and advance clinical development, overcome the key GMP manufacturing and scale-up challenges, whilst also discovering and applying microbiome biomarkers for improved clinical outcomes. 

This event  is the most comprehensive forum for microbiome drug developers and the perfect opportunity for the industry to take a collaborative approach to close the clinical gap, discover the next generation of microbiome-based therapeutics, and establish new partnerships to accelerate your research.

Join us Back Face to Face

Join us back in person for the first time in two years to feel the full force of networking together to create those all important partnership opportunities that will accelerate your therapeutic program development

Brand New Double Streamed Pre-Conference Day

From workshops on working with CDMO’s, gut-brain axis, and microbiome-derived liquid biopsy, alongside an immune disease focus day, make sure you add an extra day of learning this June

Five Panel Discussions

Featuring leading experts: the GMP manufacturing and scale-up panel will help you prepare to progress your pipeline, the clinical trial panel will optimize your knowledge for successful clinical results, and the regulatory and legislative panel will give you the know-how to ensure the smoothest journey to an approved microbiome therapeutic 

End-to-End Content Coverage

Track A - Deep-dive into microbiome functionality and pre-clinical development. Track B - Discover insights into clinical translation. Track C - Learn about manufacturing, scale-up, and commercialization.
Better yet, bring your team and access all 3 tracks for a discounted price!

Expert Speakers Include

Antonio DiGiandomenico

Director of Microbiome Discovery

AstraZeneca

Dirk Gevers

Global Head Janssen Human Microbiome Institute

Janssen Research & Development

Jessica Schneider

Director of Gastroenterology

Takeda

Mark Carbonneau

Sr. Director, Head of Translational Science

Synlogictx

Matthew Henn PhD

Chief Scientific Officer

Seres Therapeutics

Paul Carlson, Ph.D.

Principal Investigator

FDA

Serge Sagodira

Director Licensing Transactions

Debiopharm

Stewart Campbell

CEO

Axial Therapeutics

Hear What the Microbiome Community Says

"The Microbiome Movement – Drug Development Summit is the premier meeting in the microbiome field, and a “must-attend” for those involved in microbiome related drug development”

Blake Wise, Novome Biotechnologies

"This summit offers great opportunity for researchers to share findings and advancements in the microbiome field, and greatly fosters the development of microbiome-based therapeutics and diagnostis

Xue Liang, Merck Exploratory Science

Our 2022 Partners

Lead Partner

Hosting Partner

Expertise Partners

Other Confirmed Partners

Other Events In The Series